Cancer News and Research

Latest Cancer News and Research

Weill Cornell Medical College researcher wins 2012 William B. Coley Award

Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and provost for medical affairs of Cornell University, is a winner of the 2012 William B. Coley Award for Distinguished Research in Basic Immunology from the Cancer Research Institute for her outstanding achievements in immunology and cancer research.

19 Oct 2012

Study hopes to improve the outlook for native Americans with kidney disease

Americans have a 1 in 10 chance of suffering from kidney disease, according to statistics from the Centers for Disease Control and Prevention. For Native Americans, the risk doubles.

19 Oct 2012

Viewpoints: NYT's Kristof on the death of his friend; Obama, Romney fight for women

I wrote in my last column about my uninsured college roommate, Scott Androes, and his battle with Stage 4 prostate cancer - and a dysfunctional American health care system. I was taken aback by how many readers were savagely unsympathetic. "Your friend made a foolish choice, and actions have consequences," one reader said in a Twitter message.

19 Oct 2012

Study identifies new risk factors for bladder cancer

Low depressive symptoms and a longer telomere length are compelling factors that contribute to a prolonged life for bladder cancer patients according to researchers at The University of Texas MD Anderson Cancer Center.

19 Oct 2012

Lupus investigators receive LRI's first $1 million research grants

The Lupus Research Institute (LRI) today announced the first $1 million research grants given to lupus investigators by a private research organization.

19 Oct 2012

Electronic health record use linked to higher quality care

The use of electronic health records is linked to significantly higher quality care, according to a new study- by Lisa Kern and her team, from the Health Information Technology Evaluation Collaborative in the US. Their work appears online in the Journal of General Internal Medicine-, published by Springer.

19 Oct 2012

New book focuses on Wnt signaling

Wnt proteins are signaling molecules that play critical roles during embryonic development and in the regeneration of adult tissues. They bind to Frizzled and LRP family receptors on the cell surface, triggering a series of events that cause beta-catenin to enter the nucleus and activate transcription factors that control cell fate and cell proliferation. Mutations in components of the Wnt pathway lead to developmental defects and are common in cancer.

19 Oct 2012

Study demonstrates cancer control essential for development progress, researcher says

Using data from cancer registries worldwide, researchers from the International Agency for Cancer Research (IACR) found that 169.3 million years of healthy life were lost to cancer in 2008, according to a study published on Tuesday in the Lancet, HealthDay News reports.

19 Oct 2012

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI.

19 Oct 2012

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Neuralstem, Inc. announced that it has begun dosing the second cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

19 Oct 2012

Kaiser Permanente creates new electronic Exercise Vital Sign initiative

Kaiser Permanente has created a new electronic Exercise Vital Sign initiative to systematically record patients' physical activity in their electronic health records.

19 Oct 2012

Long-term multivitamin use associated with prevention of cancer in middle-aged and older men

In a randomized trial that included nearly 15,000 male physicians, long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer after more than a decade of treatment and follow-up, according to a study appearing in JAMA.

19 Oct 2012

Ustekinumab shows positive results in decreasing debilitating effects of Crohn's Disease

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn's Disease, according to researchers at the University of California San Diego, School of Medicine.

18 Oct 2012

Jersey Shore University Medical Center recognized as Baby-Friendly hospital

Jersey Shore University Medical Center has received an international designation as a Baby-Friendly hospital. Baby-Friendly USA, Inc. is the U.S. authority for the implementation of the Baby-Friendly Hospital Initiative, a global program sponsored by the World Health Organization and the United Nations Children's Fund.

18 Oct 2012

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

18 Oct 2012

Research may lead to new ways to identify women with breast cancer risks from low-dose radiation

Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have identified tissue mechanisms that may influence a woman's susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy.

18 Oct 2012

Cancer News and Research

Latest Cancer News and Research

Weill Cornell Medical College researcher wins 2012 William B. Coley Award

Study hopes to improve the outlook for native Americans with kidney disease

Viewpoints: NYT's Kristof on the death of his friend; Obama, Romney fight for women

Study identifies new risk factors for bladder cancer

Lupus investigators receive LRI's first $1 million research grants

Electronic health record use linked to higher quality care

New book focuses on Wnt signaling

Study demonstrates cancer control essential for development progress, researcher says

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Kaiser Permanente creates new electronic Exercise Vital Sign initiative

Long-term multivitamin use associated with prevention of cancer in middle-aged and older men

Ustekinumab shows positive results in decreasing debilitating effects of Crohn's Disease

Jersey Shore University Medical Center recognized as Baby-Friendly hospital

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Research may lead to new ways to identify women with breast cancer risks from low-dose radiation

Longer period of formula feeding may increase ALL risk

Pain relief from palliative RT for bone metastases improves QoL

Study examines long-term affect of multivitamins on major chronic diseases

Planned Parenthood funding, abortion and women's health issues create debate flashpoints

Industry Focus eBook - Immunology (3rd edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Immunology (3rd edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in